BioRestorative Therapies Announces Reverse Stock Split – Ortho Spine News
BioRestorative Therapies (BRTX) announced a 1-for-20 reverse stock split, effective September 7, 2026, to meet Nasdaq's $1 minimum bid price requirement. Trading will resume on September 8, 2026, under the same ticker (BRTX) with a new CUSIP. The split reduces outstanding shares from 27.6M to ~1.38M, with no change in ownership percentages.
How this was made
The 30-second read
Why it matters
The reverse split is intended to bring the stock back into compliance, which could temporarily boost liquidity and price stability, but underlying business risks remain.
Market read
Primary relevance to BRTX shareholders and short‑term traders; minimal broader market effect.
What to watch
Potential dilution from adjusted option and warrant pools and fractional share cash‑in may affect shareholder value.
Background
BioRestorative Therapies is a late‑stage regenerative medicine company with a Phase 2 trial for a disc disease therapy; its share price has been pressured by Nasdaq compliance concerns.
Ticker impact
Company announced a 1‑for‑20 reverse stock split to regain Nasdaq $1.00 minimum bid price compliance, effective Sep 7 with trading on Sep 8.
Short‑term upside as price adjusts upward; long‑term impact depends on post‑split trading and underlying business performance.
Reverse splits are a clear, material corporate action that directly affects share structure and listing status; traders can act on the upcoming price adjustment.
Market effects
May improve perception of biotech/regen‑med sector compliance risk, but limited broader sector impact.
Primarily affects US Nasdaq micro‑cap market; no significant regional effect.
Low global relevance; only relevant to investors in BRTX.
Counterpoint
If the split fails to sustain price above $1, the stock could face renewed delisting risk, leading to further downside.
Key entities
- companyBioRestorative Therapies, Inc.
Nasdaq‑listed regenerative medicine firm executing a reverse split.
- service_providerTranShare Corporation
Transfer agent handling the share exchange.
